Nitto Avecia (part of Nitto Denko Corporation) is a US-based CDMO specializing in oligonucleotide drug substance manufacturing with over 25 years of experience. The company provides comprehensive services from preclinical manufacturing (OliGrow service) through commercial scale, including analytical development, process development, drug substance manufacturing, process performance qualification (PPQ), quality control, and stability testing. It achieved ANVISA GMP certification in 2025.
oligonucleotide API manufacturing, OliGrow preclinical manufacturing service, siRNA and antisense oligonucleotide production, analytical method development and validation, CMC services
1 site worldwide
No reviews available yet.
No documents available.